Injectable Drug Delivery 2019 Conference

May 15-16, 2019 - London, United Kingdom

Conference Proceedings

Standard Price

US$ 623.75

User Details

We are pleased to announce the second annual Injectable Drug Delivery conference which will be held in London on the 15th and 16th May 2019.

The global injectable drug delivery market is expected to grow from $400 billion to $1200 billion by 2046 with a CAGR of 12.8%.

Injectable drug delivery
is a method of drug administration into the body with a needle via various routes including intramuscular and intravenous. These are examples of conventional drug delivery. Recently, there has been a focus on novel drug delivery, including needle-free injectors, and transdermal patches. Long acting injectables (LAI) are developing fast as a push towards patient centric devices drives the industry. Habitually, injectables were used for delivery of hormones, vaccines and insulin but as technology advances the application is continuing to expand. Now there is an emphasis on finding solutions to chronic conditions and the biological drugs required involve formulation development challenges for proteins, including high viscosity and high volume. Self-administrative, connected, and ergonomic devices are the new drive. Self-injectable devices include pen injectors for diabetic patients. The wealth of expansion available in the field of connected devices is huge. The regulatory landscape is challenging as it evolves rapidly with the market demand for new devices.

Benefits of Attending

Developing on last years success, this event assembles an international audience to include regulatory, device design, packaging and  formulation professionals.  The devices need to be designed for the new generation of drugs and they need to provide safety with a strong patient focus. This event is will help inspire you to help drive this industry forward and learn about the predicted market trends, critical digital and chemical developments and the push for patient compliance in a changing regulatory landscape.

This conference offers a chance to learn about innovative injectable drug delivery systems with industrial insights on the following:
  • Life cycle management for developing devices that are both user friendly and revenue effective
  • Device design considerations
  • Long acting injectables and bringing these therapeutics to market with case studies
  • Connected devices, GDPR and cyber security programs
  • Developments in primary packaging
  • Growth in transdermal delivery and subcutaneous infusion devices
  • Digital health partnerships
  • Large volume patch pump innovation examples

Who should attend

Executives, Directors, VPs, Heads, Principals, Managers, Scientists, Researchers of:
  • Autoinjectors
  • Wearables
  • Device Engineering
  • Human Factors
  • CMC
  • Injectables
  • Sterile Manufacturing
  • Packaging
  • Regulatory Affairs

Plus an Interactive Half-Day Pre-Conference Workshop | Tuesday 14th May 2019

Use-related Risk Analysis throughout a Design and Development Project
Workshop Leader: Paula Wood, Director, Human Factors Centre
13.30 - 17.30


  • Adeline Meilhoc, VP Sales & Marketing, Eveon
  • Blake Green, Senior Manager Regulatory Affairs, Amgen
  • Edward Sims, Senior Designer & Associate , Crux Product Design, Ltd
  • Joel Richard, Head of Technical & Pharmaceutical Operations, MedinCell
  • John Burke, Senior Consultant, Team Medical Devices
  • Louisa Harvey, Director, Harvey Medical Consulting Ltd
  • Mayur Patel, Leading innovative medical and combination product development, PA Consulting
  • Miranda Newbery, Human Factors Consultant, Inspired Usability
  • Olaf Lebau, Design Engineer for Medical Device and Combination products, Boehringer Ingelheim GmbH
  • Paul Kinsey, QA Manager, GSK
  • Quentin Le Masne, Head of Engineering team - Electro-Medical, Drug Delivery Devices, Merck
  • Sigrid Van Dyck, Senior Director Technical Operations, Janssen Supply Chain, Johnson & Johnson
  • Stephen Paboojian, Senior New Technology Project Leader II, Novartis Pharma AG
  • Terry Reed, Director Business Development, AstraZeneca
  • Tom Lawrie-Fussey, Head of Digital Health, Cambridge Design Partnership
  • Vasco Filipe, Senior research scientist - Formulation Development, Sanofi

Please fill in your name and email to receive the Conference Agenda of this event.


Copthorne Tara Hotel
Scarsdale Pl, Kensington, W8 5SY
London, UK


Copthorne Tara Hotel
Scarsdale Place, Kensington
London, United Kingdom
Event details
Organizer :SAE Media Group
Event type :Conference
Attendance :Physical Event
Reference :ASDE-20280